Siparex has announced the equity restructuring of Malherbe group, a French five lot and consolidated shipment company. The company’s management, headed by chairman Alain Samson, will be the majority owner, alongside a new group of financial investors comprising Siparex, CDC Entreprises (investing under the FSI France Investissement program), UNEXO, Socadif, and NCI. The fund Siparex MidMarket III is making its debut investment on this deal, in which NiXEN Partners is selling its stake.

Calixar SAS said it received initial funding of EUR 875,000 ($1.1 million) from Siparex, Veymont Participations, INPG Entreprise SA and regional business angels from the Health-Angels Rhone-Alpes, Savoie Angels and Grenoble Angels networks.The company develops membrane protein services. PRESS RELEASE Calixar closes an initial EUR 875,000 funding round The funds will enable the Lyon-based membrane [...]

Calixar, a French start-up providing services focused on membrane proteins, has completed an initial funding round of 875,000 euros ($1.1 million) from private investors including Siparex, Veymont Participations, INPG Entreprise SA, and regional business angels from the Health-Angels Rhone-Alpes, Savoie Angels and Grenoble Angels networks. PRESS RELEASE Calixar SAS, a start-up providing services focused on [...]

French private equity firm NiXEN is to to acquire a controlling interest in Babeau Seguin Group, a builder of single-family detached homes. Management is making a substantial re-investment in the business alongside historical financial partners Siparex (lead financier of the previous transaction), CM-CIC, Carvest and Somfy Participations. Pechel and Avenir Entreprises will also support the [...]